There are many ways to be explored, such as the common pathway of the formation of dementia-related protein; the synergy and interaction among Aβ, tau, TDP-43 as well as other related pathological protein; the real role of progranulin in LATE and the mechanism of Methylene blue and dimebon therapy in LATE. The gene discussed is GRN; the disease is dementia.